How should decreased 18F‑FDG uptake in the temporal lobes on PET/CT be described?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Describing Decreased FDG Uptake in Temporal Lobes on PET/CT

Decreased 18F-FDG uptake in the temporal lobes should be described as "temporal lobe hypometabolism" or "reduced glucose metabolism in the temporal region," with specific anatomical localization (medial vs. lateral, anterior vs. posterior) and laterality clearly stated.

Standardized Terminology

The appropriate descriptive terms for decreased FDG uptake include:

  • "Hypometabolism" - This is the most widely accepted term in clinical practice and research 1
  • "Decreased FDG uptake" or "reduced FDG uptake" - Direct descriptive terminology 2
  • "Decreased glucose metabolism" - Reflects the underlying pathophysiology 3

Essential Components of the Description

When reporting temporal lobe FDG findings, your description must include:

1. Anatomical Specificity

Specify the exact temporal lobe subregion involved:

  • Medial temporal lobe (including hippocampus) 1
  • Lateral temporal lobe 1
  • Anterior temporal cortex (medial anterior temporal [MAT] or lateral anterior temporal [LAT]) 4
  • Posterior temporal cortex (medial posterior temporal [MPT] or lateral posterior temporal [LPT]) 4

2. Laterality and Asymmetry

  • State whether the hypometabolism is unilateral or bilateral
  • If unilateral, calculate and report an asymmetry index (AI) when possible 4, 5
  • Document the degree of asymmetry between hemispheres, as this has prognostic implications 4

3. Severity Grading

Grade the hypometabolism as 6:

  • None
  • Mild
  • Moderate
  • Severe

This severity correlates with underlying pathophysiology and clinical outcomes 6.

4. Distribution Pattern

Note whether hypometabolism is:

  • Focal (confined to temporal lobe)
  • Regional (extending beyond temporal lobe to parietal, occipital, or other regions) 1

Clinical Context Matters

The interpretation and description should be tailored to the clinical indication:

For Dementia/Cognitive Impairment Evaluation

  • Alzheimer's Disease pattern: Describe hypometabolism in medial temporal lobe and posterior cingulate 1
  • Dementia with Lewy Bodies pattern: Note if hypometabolism extends to parieto-occipital regions in addition to temporal lobes 1
  • Patients with MCI progressing to dementia show lower FDG uptake in temporal and parietal cortex 1

For Epilepsy Evaluation

  • Describe the epileptogenic zone with precise localization 7, 8
  • Document quantitative asymmetry between epileptic and non-epileptic temporal lobes 4
  • Note any extratemporal extension of hypometabolism 7

Quantitative Measures to Include

Beyond visual description, incorporate semiquantitative parameters when available 5:

  • SUV (Standardized Uptake Value) - absolute metabolic activity 4, 5
  • SUVr (SUV ratio) - relative to reference region 7
  • Asymmetry Index (AI) - quantifies left-right differences 4
  • MTV (Metabolic Tumor Volume) and TLG (Total Lesion Glycolysis) - for oncologic applications 9

Important caveat: Quantitative analysis is particularly critical for subtle findings and extratemporal lesions where visual analysis alone may miss pathology 8. For temporal lobe epilepsy specifically, prioritize describing the regions of hypometabolism over absolute uptake values, as the pattern matters more than the degree 7.

Common Pitfalls to Avoid

  1. Don't use vague terminology like "decreased activity" without specifying glucose metabolism or FDG uptake
  2. Don't omit laterality - always state which temporal lobe(s) are affected
  3. Don't ignore extratemporal involvement - temporal hypometabolism often extends to adjacent regions 1, 7
  4. Don't rely solely on visual assessment for subtle findings - quantitative analysis improves detection 8, 5
  5. Don't forget to account for normal age-related variations in pediatric patients, where FDG uptake increases until age 12-13 10

Technical Considerations

Per FDA labeling, optimal PET imaging should be initiated within 40 minutes of FDG injection 3. Blood glucose should be stabilized before injection, as fasting status and diabetic control affect FDG uptake 3. These factors should be documented if they may impact interpretation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.